Lilly Offloads Baqsimi To Amphastar While Investing In Mounjaro Head-To-Head Trial

Hypoglycemia
Lilly divests glucagon spray product to Amphastar for $500m • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business